Clinical Trial: Evaluation of the FluidVisionTM AIOL With an Improved Injector
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Clinical Evaluation of the FluidVisionTM Accommodating Intraocular Lens With an Improved Injector System
Brief Summary: The objective of this study is to evaluate the clinical outcomes of an accommodating intraocular lens (AIOL) designed to provide distance, intermediate, and near vision in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.
Detailed Summary:
Sponsor: PowerVision
Current Primary Outcome:
- Visual Acuity [ Time Frame: 3 months ]
- Visual Acuity [ Time Frame: 6 months ]
- Visual Acuity [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: PowerVision
Dates:
Date Received: April 9, 2015
Date Started: January 2015
Date Completion: October 2018
Last Updated: April 25, 2016
Last Verified: April 2016
